印度BSE Sensex指数周四收于83014点，上涨约0.4%，为7月10日以来的最高水平，连续第三个交易日上涨。IT和制药股领涨，因美联储恢复政策宽松并暗示将进一步削减，而对正在进行的美印贸易谈判的乐观情绪增加了支撑。美国药品监管机构对其他印度公司（即Biocon和Natco Pharma）的有利监管行动进一步推动了制药行业的发展。在贸易方面，首席经济顾问V.Anantha Nageswaran表示，美国可能会在11月30日前降低对印度商品25%的惩罚性关税，并将互惠关税降至10-15%，这可能使近500亿美元的出口受益。在股票中，Eternal、Sun Pharma、Infosys、HDFC Bank和Power Grid表现最佳，涨幅高达2.9%，而Bajaj Finance、Trent、Tata Motors、UltraTech Cement和Asian Paints的跌幅高达1%。
India's BSE Sensex closed about 0.4% up at 83,014 on Thursday, a high level not seen since July 10 and extending gains for a third straight session. Gains were led by IT and pharmaceutical shares as the Federal Reserve resumed policy easing and hinted at more cuts, while optimism over ongoing US-India trade talks added support. The pharmaceutical sector received an additional boost from favorable regulatory actions by the US drug regulator involving other Indian companies, namely Biocon and Natco Pharma. On the trade front, Chief Economic Adviser V. Anantha Nageswaran indicated that the US is likely to roll back its 25% punitive tariff on Indian goods and cut reciprocal duties to 10–15% by November 30, potentially benefiting nearly $50 billion in exports. Among equities, Eternal, Sun Pharma, Infosys, HDFC Bank, and Power Grid were top performers, rising as much as 2.9%, while Bajaj Finance, Trent, Tata Motors, UltraTech Cement, and Asian Paints recorded losses up to 1%.
